Shanmuga Hospital reported Q1 FY27 revenue of ₹11.87 crore, a slight increase from last year. The company also approved an Employee Stock Option Plan and plans to increase authorized share capital, signaling strategic expansion and diversification.
Shanmuga Hospital Reports Q1 FY27 Growth, Approves ESOP
Q1 FY27 Revenue: ₹11.87 crore
Q1 FY27 Net Profit: ₹0.99 crore
Reader Takeaway: Steady revenue growth with strategic diversification into IT and support services.
What just happened
Shanmuga Hospital Ltd. announced its financial results for the first quarter of Fiscal Year 2027 (ending June 2026). The company recorded a revenue of ₹11.87 crore, a marginal increase from ₹11.48 crore in the same quarter last year. Net profit stood at ₹0.99 crore, also showing a slight improvement from ₹0.95 crore in Q1 FY26. The Board of Directors approved the 'Shanmuga Hospital Limited Employee Stock Option Plan 2026' (SHL ESOP-2026), allowing for the grant of up to 3,50,000 stock options. Additionally, a proposal to increase the authorized share capital from ₹14 crore to ₹25 crore was approved, pending shareholder consent.
Why this matters
These developments indicate a focus on both steady operational performance and future growth initiatives. The ESOP plan aims to incentivize employees, while the capital restructuring will provide the company with greater financial flexibility for expansion. The diversification into IT and medical support services signals a strategy to unlock new revenue streams beyond its core hospital operations.
The backstory
Shanmuga Hospital has been operating with a focus on healthcare services. The recent filing shows a consistent, albeit modest, revenue growth trend over the past year. The company's paid-up equity share capital is currently around ₹13.56 crore, with the proposed ESOP representing approximately 2.58% of this. The authorized capital was previously ₹14 crore.
What changes now
The approval of the ESOP plan means the company can now grant stock options to its employees, subject to plan specifics. The proposed increase in authorized capital will require shareholder approval at the upcoming Annual General Meeting (AGM) and will enable the company to issue more shares in the future. Amendments to the Memorandum of Association will allow the company to officially engage in administrative and IT support services.
Risks to watch
A key watch point is a reported discrepancy in the Power Purchase Agreement (PPA) tariff with LNGS Private Limited, with internal figures showing ₹6.10 and ₹6.50 per unit in different sections. This requires clarification. The success of the diversification into IT and support services also needs to be monitored.
Peer comparison
Specific peer financial data for Q1 FY27 is not immediately available in the filing. However, the reported revenue growth is modest, suggesting a stable but not rapidly expanding market position.
Context metrics (time-bound)
- Q1 FY27 Revenue: ₹11.87 crore (June 2026 quarter)
- Q1 FY26 Revenue: ₹11.48 crore (June 2025 quarter)
- Proposed ESOP: Up to 3,50,000 options
- Proposed Authorized Capital: ₹25 crore
What to track next
Investors should closely watch the shareholder approval for the capital increase, the rollout and impact of the ESOP plan, and the financial performance of the newly diversified business segments. Clarification on the PPA tariff discrepancy is also important.
